patient enrollment | DEEP Project

DEEP-2 study completed the enrollment!

Sun, 14 Aug 2016 05:52:46 +0000

A big project milestone has been reached as the last few patients have been randomized. Thanks to the last achievements and efforts made by the PIs to recruit patients, the DEEP-2 Study has finally completed the enrollment.

The last patients were included in Albania, Italy and UK while the 393rd patient has been randomized on 14/7/2016 in UK.

An important action carried out by the DEEP-2 Trial Management Team aimed at ensuring the correct implementation of the study protocol is the release of a monthly DEEP-2 study newsletter (available on the DEEP website in the Study Newsletter section), that is sent to all PIs and also available on the website, aimed at clarifying most of the criticisms of the study protocol.

Stay connected with the DEEP website and social networks (Facebook and Google+) to be updated.

The post DEEP-2 study completed the enrollment! first appeared on DEEP Project.]]>

Update of Centres involved

Mon, 03 Aug 2015 18:55:13 +0000

Another step forward has been made toward the enrollment of new patients, which is allowed by the end of October 2015.

Principal Investigators (PIs) are still working to continue the enrollment of patients within the DEEP-2 study and to date a total of 117 patients have been already included in 12 recruiting centres: Italy (43), Egypt (53), Greece (6), Albania (15). Further 2 centers are very close to recruit their first patients and 10 recruiting centres are still waiting for receiving the approval/Site Initiation Visit. In order to be sure to reach the planned number of patients, 3 new centres in Turkey (Hacettepe University, Faculty of Medicine in Ankara; Istanbul University, Cerrahpaşa Faculty of Medicine in Istanbul; Kanuni Sultan Suleyman TRH in Istanbul), 1 in Lebanon (Nini Hospital in Tripoli), 1 in Albania (Hospital ‘Ihsan Çabej’, Lushnjë) and 1 in Qatar (National Center for Cancer Care and Research, Doha) are being activated.

Total number of centers will then be 30.

Stay connected with the DEEP website and discover the counter on the homepage to be updated on the DEEP-2 patients recruitment status!

The post Update of Centres involved first appeared on DEEP Project.]]>

DEEP-1 – First patient enrolled!

Thu, 04 Apr 2013 10:07:08 +0000

On January 31st, 2013 recruitment started in the DEEP-1 study (multi-centre, oral single dose experimental and modelling study to evaluate the pharmacokinetics of deferiprone in patients aged from 1 month to less than 6 years of age affected by transfusion-dependent haemoglobinopathies) and the first patient was enrolled at the Azienda Ospedaliera “A. Cardarelli” in Naples.

The post DEEP-1 – First patient enrolled! first appeared on DEEP Project.]]>

DEEP-3 – First patient enrolled!

Thu, 04 Apr 2013 09:00:04 +0000

On February 15th 2013 recruitment started for the DEEP-3 study (multi-centre, long-term observational safety study to evaluate the nature and incidence of adverse effects of deferiprone treatment in patients with beta-thalassaemia major aged from 1 month to less than 18 years). The first patient was enrolled at the ‘Agia Sofia’ Children’s Hospital, University of Athens in Greece.

The post DEEP-3 – First patient enrolled! first appeared on DEEP Project.]]>